Transplantation of purified HSCs transduced with BCR/ABL1 retrovirus typically gives rise to CML, however loss of both Cdkn2a/p19ARF or only p19ARF in donor cells gives rise to B ALL (165). This evidence concerns the gene CDKN2A and chronic myelogenous leukemia, BCR-ABL1 positive.